Clinical Focus

Biosimilars

More in Biosimilars

FDA Committee Backs Rituximab Biosimilar for Lymphoma

Unanimous approval recommendation for CT-P10 in NHL

Oct 10, 2018
image
Neulasta Biosimilar OK'd

First copycat for blockbuster white cell booster

Jun 04, 2018
image